Eupraxia Pharmaceuticals Reports Third Quarter 2022 Financial Results
/CNW/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX), a Phase 2 clinical-stage biotechnology company with an innovative drug...
Source: newswire.ca